Sfoglia per Autore
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses
2023-01-01 del Rosario Garcia-Lozano, M.; Dragoni, F.; Gallego, P.; Mazzotta, S.; Lopez-Gomez, A.; Boccuto, A.; Martinez-Cortes, C.; Rodriguez-Martinez, A.; Perez-Sanchez, H.; Manuel Vega-Perez, J.; Antonio Del Campo, J.; Vicenti, I.; Vega-Holm, M.; Iglesias-Guerra, F.
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage
2023-01-01 Marchi, Serena; Dragoni, Filippo; Boccuto, Adele; Idoko, Olubukola T; Zazzi, Maurizio; Sow, Samba; Aldiouma, Diallo; Viviani, Simonetta; Montomoli, Emanuele; Vicenti, Ilaria; Trombetta, Claudia Maria
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility
2022-01-01 Luongo, F. P.; Dragoni, F.; Boccuto, A.; Paccagnini, E.; Gentile, M.; Canosi, T.; Morgante, G.; Luddi, A.; Zazzi, M.; Vicenti, I.; Piomboni, P.
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations
2021-01-01 Saladini, F.; Giammarino, F.; Hosseini, B. A.; Giannini, A.; Boccuto, A.; Dragoni, F.; Vicenti, I.; Shafer, R. W.; Zazzi, M.
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2
2021-01-01 Vicenti, Ilaria; Martina, Maria Grazia; Boccuto, Adele; De Angelis, Marta; Giavarini, Giorgia; Dragoni, Filippo; Marchi, Serena; Trombetta, Claudia Maria; Crespan, Emmanuele; Maga, Giovanni; Eydoux, Cecilia; Decroly, Etienne; Montomoli, Emanuele; Nencioni, Lucia; Zazzi, Maurizio; Radi, Marco
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects
2021-01-01 Vicenti, I.; Gatti, F.; Scaggiante, R.; Boccuto, A.; Zago, D.; Basso, M.; Dragoni, F.; Parisi, S. G.; Zazzi, M.
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study
2021-01-01 Cirri, D.; Marzo, T.; Tolbatov, I.; Marrone, A.; Saladini, F.; Vicenti, I.; Dragoni, F.; Boccuto, A.; Messori, L.
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects
2021-01-01 Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Basso, Monica; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro
2021-01-01 Boccuto, A.; Dragoni, F.; Picarazzi, F.; Lai, A.; Ventura, C. D.; Veo, C.; Giammarino, F.; Saladini, F.; Zehender, G.; Zazzi, M.; Mori, M.; Vicenti, I.
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir
2021-01-01 Saladini, Francesco; Giannini, Alessia; Giammarino, Federica; Boccuto, Adele; Dragoni, Filippo; Vicenti, Ilaria; Zazzi, Maurizio
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses
2021-01-01 Martina, Maria Grazia; Vicenti, Ilaria; Bauer, Lisa; Crespan, Emmanuele; Rango, Enrico; Boccuto, Adele; Olivieri, Noemi; Incerti, Matteo; Zwaagstra, Marleen; Allodi, Marika; Bertoni, Simona; Dreassi, Elena; Zazzi, Maurizio; van Kuppeveld, Frank J M; Maga, Giovanni; Radi, Marco
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells
2021-01-01 Vicenti, Ilaria; Dragoni, Filippo; Monti, Martina; Trombetta, Claudia Maria; Giannini, Alessia; Boccuto, Adele; Saladini, Francesco; Rossetti, Barbara; De Luca, Andrea; Ciabattini, Annalisa; Pastore, Gabiria; Medaglini, Donata; Orofino, Giancarlo; Montomoli, Emanuele; Zazzi, Maurizio
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose
2021-01-01 Vicenti, Ilaria; Basso, Monica; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Modolo, Eliana; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection
2021-01-01 Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Basso, Monica; Dragoni, Filippo; Zazzi, Maurizio; Parisi, Saverio Giuseppe
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals
2021-01-01 Boccuto, A.; Dragoni, F.; Bergna, A.; Ventura, C. D.; Giammarino, F.; Saladini, F.; Pezzati, L.; Zehender, G.; Zazzi, M.; Vicenti, I.; Lai, A.
Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection
2021-01-01 Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Modolo, Eliana; Zago, Daniela; Basso, Monica; Dragoni, Filippo; Bartolini, Niccolo'; Zazzi, Maurizio; Parisi, Saverio Giuseppe
Novel antiviral strategies against emerging viral diseases
2020-01-01 Boccuto, A.
Zika virus in west africa: A seroepidemiological study between 2007 and 2012
2020-01-01 Marchi, S.; Viviani, S.; Montomoli, E.; Tang, Y.; Boccuto, A.; Vicenti, I.; Zazzi, M.; Sow, S.; Diallo, A.; Idoko, O. T.; Bhat, N.; Trombetta, C. M.
Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses
2020-01-01 Riva, V.; Garbelli, A.; Brai, A.; Casiraghi, F.; Fazi, R.; Trivisani, C. I.; Boccuto, A.; Saladini, F.; Vicenti, I.; Martelli, F.; Zazzi, M.; Giannecchini, S.; Dreassi, E.; Botta, M.; Maga, G.
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication.
2020-01-01 Vicenti, I; Dragoni, F; Giannini, A; Giammarino, F; Spinicci, M; Saladini, F; Boccuto, A; Zazzi, M.
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses | 1-gen-2023 | del Rosario Garcia-Lozano, M.; Dragoni, F.; Gallego, P.; Mazzotta, S.; Lopez-Gomez, A.; Boccuto, A.; Martinez-Cortes, C.; Rodriguez-Martinez, A.; Perez-Sanchez, H.; Manuel Vega-Perez, J.; Antonio Del Campo, J.; Vicenti, I.; Vega-Holm, M.; Iglesias-Guerra, F. | - | |
| Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage | 1-gen-2023 | Marchi, Serena; Dragoni, Filippo; Boccuto, Adele; Idoko, Olubukola T; Zazzi, Maurizio; Sow, Samba; Aldiouma, Diallo; Viviani, Simonetta; Montomoli, Emanuele; Vicenti, Ilaria; Trombetta, Claudia Maria | - | |
| SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility | 1-gen-2022 | Luongo, F. P.; Dragoni, F.; Boccuto, A.; Paccagnini, E.; Gentile, M.; Canosi, T.; Morgante, G.; Luddi, A.; Zazzi, M.; Vicenti, I.; Piomboni, P. | - | |
| In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations | 1-gen-2021 | Saladini, F.; Giammarino, F.; Hosseini, B. A.; Giannini, A.; Boccuto, A.; Dragoni, F.; Vicenti, I.; Shafer, R. W.; Zazzi, M. | - | |
| System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 | 1-gen-2021 | Vicenti, Ilaria; Martina, Maria Grazia; Boccuto, Adele; De Angelis, Marta; Giavarini, Giorgia; Dragoni, Filippo; Marchi, Serena; Trombetta, Claudia Maria; Crespan, Emmanuele; Maga, Giovanni; Eydoux, Cecilia; Decroly, Etienne; Montomoli, Emanuele; Nencioni, Lucia; Zazzi, Maurizio; Radi, Marco | - | |
| BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects | 1-gen-2021 | Vicenti, I.; Gatti, F.; Scaggiante, R.; Boccuto, A.; Zago, D.; Basso, M.; Dragoni, F.; Parisi, S. G.; Zazzi, M. | - | |
| In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study | 1-gen-2021 | Cirri, D.; Marzo, T.; Tolbatov, I.; Marrone, A.; Saladini, F.; Vicenti, I.; Dragoni, F.; Boccuto, A.; Messori, L. | - | |
| The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects | 1-gen-2021 | Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Basso, Monica; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio | - | |
| Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro | 1-gen-2021 | Boccuto, A.; Dragoni, F.; Picarazzi, F.; Lai, A.; Ventura, C. D.; Veo, C.; Giammarino, F.; Saladini, F.; Zehender, G.; Zazzi, M.; Mori, M.; Vicenti, I. | - | |
| In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir | 1-gen-2021 | Saladini, Francesco; Giannini, Alessia; Giammarino, Federica; Boccuto, Adele; Dragoni, Filippo; Vicenti, Ilaria; Zazzi, Maurizio | - | |
| Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses | 1-gen-2021 | Martina, Maria Grazia; Vicenti, Ilaria; Bauer, Lisa; Crespan, Emmanuele; Rango, Enrico; Boccuto, Adele; Olivieri, Noemi; Incerti, Matteo; Zwaagstra, Marleen; Allodi, Marika; Bertoni, Simona; Dreassi, Elena; Zazzi, Maurizio; van Kuppeveld, Frank J M; Maga, Giovanni; Radi, Marco | - | |
| Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells | 1-gen-2021 | Vicenti, Ilaria; Dragoni, Filippo; Monti, Martina; Trombetta, Claudia Maria; Giannini, Alessia; Boccuto, Adele; Saladini, Francesco; Rossetti, Barbara; De Luca, Andrea; Ciabattini, Annalisa; Pastore, Gabiria; Medaglini, Donata; Orofino, Giancarlo; Montomoli, Emanuele; Zazzi, Maurizio | - | |
| Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose | 1-gen-2021 | Vicenti, Ilaria; Basso, Monica; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Modolo, Eliana; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio | - | |
| Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection | 1-gen-2021 | Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Basso, Monica; Dragoni, Filippo; Zazzi, Maurizio; Parisi, Saverio Giuseppe | - | |
| Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals | 1-gen-2021 | Boccuto, A.; Dragoni, F.; Bergna, A.; Ventura, C. D.; Giammarino, F.; Saladini, F.; Pezzati, L.; Zehender, G.; Zazzi, M.; Vicenti, I.; Lai, A. | - | |
| Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection | 1-gen-2021 | Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Modolo, Eliana; Zago, Daniela; Basso, Monica; Dragoni, Filippo; Bartolini, Niccolo'; Zazzi, Maurizio; Parisi, Saverio Giuseppe | - | |
| Novel antiviral strategies against emerging viral diseases | 1-gen-2020 | Boccuto, A. | - | |
| Zika virus in west africa: A seroepidemiological study between 2007 and 2012 | 1-gen-2020 | Marchi, S.; Viviani, S.; Montomoli, E.; Tang, Y.; Boccuto, A.; Vicenti, I.; Zazzi, M.; Sow, S.; Diallo, A.; Idoko, O. T.; Bhat, N.; Trombetta, C. M. | - | |
| Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses | 1-gen-2020 | Riva, V.; Garbelli, A.; Brai, A.; Casiraghi, F.; Fazi, R.; Trivisani, C. I.; Boccuto, A.; Saladini, F.; Vicenti, I.; Martelli, F.; Zazzi, M.; Giannecchini, S.; Dreassi, E.; Botta, M.; Maga, G. | - | |
| Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. | 1-gen-2020 | Vicenti, I; Dragoni, F; Giannini, A; Giammarino, F; Spinicci, M; Saladini, F; Boccuto, A; Zazzi, M. | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile